secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOHNSON & JOHNSON (JNJ)
CIK:        0000200406
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0000200406-24-000053
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Johnson & Johnson fully divests remaining Kenvue stake via debt-for-equity exchange
--------------------------------------------------------------------------------

- On May 17, 2024, JNJ exchanged its remaining 182.3M Kenvue shares for $3.6B commercial paper, eliminating its Kenvue ownership.
- JNJ issued $3.6B commercial paper on May 15, 2024 for general corporate purposes, then used it to complete the exchange.
- This completes the separation of Consumer Health business announced in Nov 2021; JNJ no longer holds any Kenvue shares.
- The commercial paper was satisfied and discharged upon completion of the exchange.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/200406/000020040624000053/0000200406-24-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/200406/000020040624000053/jnj-20240517.htm
  HTML page:      https://secwatch.observer/filing/0000200406-24-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer